Corpak, Inc.
Manufacturer and distributor of medical devices focused on enteral nutrition delivery and pain-management solutions. Develops and supplies feeding tubes, enteral connectors and syringes, infusion delivery systems, and radiofrequency ablation devices; operates global commercial and distribution channels; provides clinical education and training; and maintains quality, regulatory, and clinical affairs functions to support product development, reimbursement engagement, and market access.
Industries
N/A
Nr. of Employees
small (1-50)
Corpak, Inc.
United Kingdom customer service (see source for details)
Products
Low-profile enteral feeding tubes
Feeding tubes designed for long-term enteral nutrition with reduced external profile suitable for neonatal, pediatric and adult patients.
Enteral connector and syringe systems
Enteral connectors, tamper-evident caps and syringe products and associated accessories to support safer enteral medication and nutrition delivery.
Radiofrequency ablation systems and probes
Device systems and probe technologies for cooled and conventional radiofrequency ablation targeting multiple anatomical sites for chronic musculoskeletal pain.
Infusion delivery systems for postoperative pain
Infusion pumps and disposable system components enabling continuous local anesthetic delivery for postoperative pain management, including elastomeric and disposable electronic platforms.
Low-profile enteral feeding tubes
Feeding tubes designed for long-term enteral nutrition with reduced external profile suitable for neonatal, pediatric and adult patients.
Enteral connector and syringe systems
Enteral connectors, tamper-evident caps and syringe products and associated accessories to support safer enteral medication and nutrition delivery.
Radiofrequency ablation systems and probes
Device systems and probe technologies for cooled and conventional radiofrequency ablation targeting multiple anatomical sites for chronic musculoskeletal pain.
Infusion delivery systems for postoperative pain
Infusion pumps and disposable system components enabling continuous local anesthetic delivery for postoperative pain management, including elastomeric and disposable electronic platforms.
Services
Self-paced clinical courses, webinars, workshops, cadaver labs, peer-to-peer site training, and continuing-education content delivered via a learning platform.
Lectures, peer-to-peer consults, cadaver labs, and on-site training to support adoption of radiofrequency ablation and other interventional pain procedures.
Patient support community and mobile application providing educational content, nurse support, and resources for patients using enteral feeding devices.
Self-paced clinical courses, webinars, workshops, cadaver labs, peer-to-peer site training, and continuing-education content delivered via a learning platform.
Lectures, peer-to-peer consults, cadaver labs, and on-site training to support adoption of radiofrequency ablation and other interventional pain procedures.
Patient support community and mobile application providing educational content, nurse support, and resources for patients using enteral feeding devices.
Expertise Areas
- Enteral nutrition systems
- Radiofrequency ablation for chronic pain
- Infusion delivery technologies for postoperative pain
- Medical device regulatory and reimbursement engagement
Key Technologies
- Cooled radiofrequency ablation
- Conventional radiofrequency ablation
- Multi-tined radiofrequency probes
- Elastomeric infusion pumps
News & Updates
CMS finalized separate payment eligibility and unique HCPCS codes for qualifying non-opioid infusion delivery systems effective January 1, 2025, including payment indicators and payment limitation guidance for qualifying devices.
Resource page explaining the NOPAIN Act, qualifying criteria for non-opioid devices in outpatient and ASC settings, HCPCS codes, payment indicators, and downloadable product catalog for reimbursement reference.
Transitioned responsibility for sales and distribution of low-profile enteral feeding products in the United Kingdom to direct operations effective July 25, 2025, to improve customer support and product availability.
Announced agreement to acquire a manufacturer of radiofrequency products and tined-probe technology to broaden the company's radiofrequency ablation portfolio for chronic pain management.
Divestiture of the respiratory health business, including associated product lines and manufacturing facility leases, as part of portfolio optimization and focus on specialty nutrition and pain management.
CMS finalized separate payment eligibility and unique HCPCS codes for qualifying non-opioid infusion delivery systems effective January 1, 2025, including payment indicators and payment limitation guidance for qualifying devices.
Resource page explaining the NOPAIN Act, qualifying criteria for non-opioid devices in outpatient and ASC settings, HCPCS codes, payment indicators, and downloadable product catalog for reimbursement reference.
Transitioned responsibility for sales and distribution of low-profile enteral feeding products in the United Kingdom to direct operations effective July 25, 2025, to improve customer support and product availability.
Announced agreement to acquire a manufacturer of radiofrequency products and tined-probe technology to broaden the company's radiofrequency ablation portfolio for chronic pain management.
Divestiture of the respiratory health business, including associated product lines and manufacturing facility leases, as part of portfolio optimization and focus on specialty nutrition and pain management.